FOXP3 and ovarian cancer: Quantitative analysis showed significant downregulation of FOXP3 and EGFR mRNA expression in SKOV3 ovarian cancer cells after 48 h of treatment with Hes, ADR, and their combination (Hes + ADR) at IC50 concentrations (Figure 8B).